Business Context and Reporting Period
Medirom Healthcare Technologies Inc., a Japanese foreign private issuer, furnished this Form 6-K for June 2023. The filing reports Nasdaq listing compliance developments and a related June 2, 2023 press release.
Key Financial Metrics
- Fiscal year referenced: Year ended December 31, 2022.
- Net income from continuing operations: $1.1 million, as reported in the company’s Form 20-F filed May 30, 2023.
- Other metrics: The filing does not provide clear values for revenue, operating profit, margins, cash flow, debt, liquidity, or cash balances.
Material Changes Versus the Prior Comparable Period
The primary development is regulatory and listing-related rather than operating or financial. On June 1, 2023, Nasdaq’s Hearings Panel determined that the company had regained compliance with Nasdaq’s net income standard under Rule 5550(b)(3) and periodic filing requirements under Rule 5250(c)(1). The Panel’s oversight process was closed.
Compliance was demonstrated through the company’s May 30, 2023 filing of its 2022 Form 20-F, which reported $1.1 million of net income from continuing operations.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Nasdaq had previously initiated delisting proceedings because the company did not meet the $35 million market value of listed securities requirement under Rule 5550(b)(2).
- The company appealed and received extensions to demonstrate compliance with the net income standard. The final extension ran through May 30, 2023.
- After the 2022 Form 20-F was filed, the company regained compliance with the net income and periodic filing requirements. The filing does not state that the market value requirement was separately satisfied.
- No revenue, earnings, cash flow, financing, or business outlook guidance is provided in this Form 6-K.
- The filing includes a June 2, 2023 press release as Exhibit 99.1. The press release is furnished, not filed, for purposes of Section 18 of the Securities Exchange Act.
Important Facts for Investors to Verify
- Review the 2022 Form 20-F for the composition and sustainability of the reported $1.1 million net income from continuing operations.
- Confirm the company’s continuing compliance with Nasdaq’s $35 million market value of listed securities requirement under Rule 5550(b)(2).
- Assess the company’s revenue trends, liquidity, debt obligations, cash flow, and operating margins using the 2022 Form 20-F and subsequent reports.
- Review Exhibit 99.1 and subsequent Nasdaq or company disclosures for any new listing conditions or compliance notices.